Drug Discovery

#AI #AI / data analytics / healthtech / informatics #Big pharma #Drug development #Drug discovery #GlobalData

AI and big data will continue to disrupt pharmaceutical sector, says research

The Covid-19 pandemic has given businesses opportunity to implement technology-fuelled changes to the way they operate. AI and big data/analytics have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes, as well as marketing and sales, according to a survey… Read More

#Market Reports #News #Trending News #Trends & Analysis

#Bioscience #Biotechnology #Cell and gene therapy #Cell and Gene Therapy Catapult #Drug development #Life sciences #Research

GSK unveils plan for one of Europe’s largest life science campuses

GSK has announced that it planning to develop its research & development site in Stevenage, UK,  into one of Europe’s largest clusters for biotechnology and early-stage life science companies. The concept has been developed in partnership with Stevenage Bioscience Catalyst (SBC), among others and would build on GSK’s existing presence,… Read More

#News

#Biopharmaceuticals #Biotechnology #Drug development #Investment #Pharmaceuticals #Therapeutics

New laboratory boosts high-potency drug development

US-based Continuus Pharmaceuticals has opened a new laboratory space and new technology to help the development of high-potency drugs. The new lab and technology are the latest developments in Continuus’ ongoing expansion, coming six months after receiving a US$69.3 million US government contract for the domestic production of medicines. “Our… Read More

#News

#Biotherapeutics #Clinical trial #Clinical Trial Authorisation #Drug delivery #Drug development #Therapeutics

FDA Fast Track designation for Parkinson’s Disease treatment

BlueRock Therapeutics has been granted Fast Track designation by the US Food and Drug Administration (FDA) for DA01 for advanced Parkinson’s disease (PD). DA01, BlueRock’s pluripotent stem cell-derived dopaminergic neuron therapy, is under evaluation in a Phase I study. “Receiving Fast Track Designation from the FDA is an important step,… Read More

#News

#3D modelling #Clinical trials #Drug development #Drug discovery

Lonza and CN Bio hepatocyte distribution agreement

Lonza and CN Bio have entered into a distribution agreement where Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in its PhysioMimix Single-and Multi-Organ MPS. The aim is to change the way human-relevant pre-clinical data is generated. With prequalified cells, customers can… Read More

#News

#Biotechnology #DNA #Drug development #Drug discovery

Pioneering DNA-encoded chemical library technology

As an expert in DNA-encoded chemical library (DEL) technology, X-Chem has set up a free-to-register, interactive virtual booth to display how it efficiently unlocks possibilities in small molecule drug discovery and development. The booth includes information about X-Chem, a video library, brochures and insert sheets on mechanical chemistry,… Read More

#News

#Cannabinoid #Drug design #Drug discovery #Medicinal cannabis #Pharma

Cultivating cannabis for pharmaceuticals: an inside view

Botanical Holdings was founded in early 2020 with a focus on investing within the legal cannabis sector. There is now a substantial body of evidence to support the effectiveness of cannabis-based medicines in treating a range of conditions from epilepsy to chronic pain. More recently, attention has also turned to… Read More

#Business & Investment #Editor's Choice #News #Opinion

#AI #AI / data analytics / healthtech / informatics #Biotherapeutics #Covid-19 #Drug design #Drug development #Therapeutics

Exscientia accelerates Covid-19 drug discovery using AI

Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the Covid-19 Therapeutics Accelerator initiative, to progress a new class of Covid-19 therapeutics created using its artificial intelligence (AI) drug design platform. Exscientia has demonstrated proof-of-concept by using its AI platform… Read More

#News

#Cancer research #Covid-19 #Drug development #Drug discovery #Drug repurposing #Research

How this chemotherapy cancer drug can be used to fight Covid-19

Mount Sinai researchers have found that widely available and inexpensive drug targeting inflammatory genes have reduced morbidity and mortality in mice infected with SARS-CoV-2. Following its publication in Cell, and reporting by DDW, Megan Thomas spoke to Dr Ivan Marazzi, co-author of the study and associate professor… Read More

#Editor's Choice #Exclusive Content #News

#Covid-19 #Drug delivery #Drug development #Drug discovery #Research

Academic investigates role of green tea compounds in Covid-19 drugs

University academic Dr Suresh Mohankumar has carried out research with colleagues in India during his time at JSS College of Pharmacy, JSS Academy of Higher Education and Research in Ooty prior to taking up his current role at Swansea University Medical School. Findings suggest that one of the compounds in… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Informatics #Lab automation #LIMS

Enhancing drug discovery with laboratory informatics and automation

Listen to this article on the DDW Podcast: Laura Marozsan, Scientific Marketing Specialist, Thermo Fisher Scientific, outlines the benefits  of automation in drug discovery. Automation plays a crucial role in modern drug discovery, enabling improvements in efficiency, standardisation, reproducibility and data integrity. An effective automated laboratory contains two main… Read More

#Exclusive Content #News

#Biomedical research #Drug discovery #Life sciences

£1 million grant will help develop new medicines in Scotland

The University of Dundee has received £1 million from the Wolfson Foundation to contribute to the costs of fitting-out the Tay Cities Regional Innovation Hub with laboratories and facilities required by high-growth biomedical companies seeking to develop new medicines and medical technologies. The Innovation Hub is central to Growing the… Read More

#News

#Awards #Clinical trials #Covid-19 #Data #Drug discovery #Immunology / Virology & Vaccines

Breakthrough Therapy Designation for single-shot chikungunya vaccine

Vaccine development company Valneva has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553, by the US Food and Drug Administration (FDA). Breakthrough Therapy Designation intends to facilitate and expedite development and review of new drugs for serious or life-threatening conditions where preliminary clinical data demonstrates that… Read More

#Editor's Choice #News

#Drug discovery #Metabolomics #Precision medicine

Partnership launches clinical metabolomics centre of excellence

Thermo Fisher Scientific and the University of California, Davis (UC Davis) West Coast Metabolomics Center have created The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and… Read More

#News

#Cancer research #Clinical trials #Drug development #Drug discovery #Tumour biology

First patient dosed with Gadeta’s gamma delta TCR cell therapy

Gadeta, a clinical-stage company developing gamma delta (γδ) T-cell receptor (TCR)-based immunotherapies for cancer patients, has announced the dosing of the first patient with GDT-002 (formerly labelled TEG002), a potential first-in-class cellular immunotherapy for the treatment of cancer. The multicentre Phase I/II study in collaboration with the Dana-Farber Cancer Institute,… Read More

#Cancer Research #News